home / stock / vvos / vvos news

VVOS News and Press, Vivos Therapeutics Inc. From 08/27/21

Stock Information
Company Name: Vivos Therapeutics Inc.
Stock Symbol: VVOS
Market: NASDAQ
Website: vivoslife.com
Menu
VVOS VVOS Quote VVOS Short VVOS News VVOS Articles VVOS Message Board
Get VVOS Alerts

News, Short Squeeze, Breakout and More Instantly...
VVOS - Study Finds That Sleep Apnea Increases Risk of Sudden Death

Research conducted by Penn State College of Medicine has discovered that individuals who are diagnosed with obstructive sleep apnea have a higher risk of sudden death in comparison with individuals who don’t have sleep apnea. Estimates show that more than one billion people global...
VVOS - InvestorNewsBreaks - Vivos Therapeutics Inc. (NASDAQ: VVOS) Partners with Empower Sleep in Effort to Improve OSA Diagnosis, Treatment

Vivos Therapeutics (NASDAQ: VVOS) , a medical technology company focused on developing and commercializing innovative diagnostic and treatment modalities for patients suffering from sleep-disordered breathing, including mild-to-moderate obstructive sleep apnea (“OSA”), is team...

VVOS - Vivos Therapeutics and Empower Sleep Launch Cooperative Relationship Aimed at Significantly Improving Proper Obstructive Sleep Apnea Diagnosis and Treatment

HIGHLANDS RANCH, Colo., Aug. 26, 2021 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc . (the “Company” or “Vivos”) (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative diagnostic and treatment modalities for patien...

VVOS - EDU, SESN and GOTU among mid-day movers

Gainers: Takung Art (NYSE:TKAT) +48%. Triple-S Management (NYSE:GTS) +45%. KLX Energy (NASDAQ:KLXE) +25%. New Oriental Education (NYSE:EDU) +26%. SkyWater Technology (NASDAQ:SKYT) +25%. Sentage (NASDAQ:SNTG) +24%. Bio-Path Holdings (NASDAQ:BPTH) +20%. TuSimple (NASDAQ:TSP) +20%. CynergisTek (...
VVOS - Triple-S Management, Bio-Path leads healthcare gainers; Theravance Biopharma, Vivos Therapeutics among major losers

Gainers: Triple-S Management (NYSE:GTS) +45%, Bio-Path (NASDAQ:BPTH) +21%, Reviva Pharmaceuticals (NASDAQ:RVPH) +21%, XTL Biopharmaceuticals (NASDAQ:XTLB) +13%, Protara Therapeutics (NASDAQ:TARA) +12%. Losers: Theravance Biopharma (NASDAQ:TBPH) ...

VVOS - Trillium Therapeutics, Vivos Therapeutics leads healthcare gainers; Flora Growth, Surgalign among major losers

Gainers: Trillium Therapeutics (NASDAQ:TRIL) +187%, Vivos Therapeutics (NASDAQ:VVOS) +57%, Xeris Pharmaceuticals (NASDAQ:XERS) +19%, ALX Oncology (NASDAQ:ALXO) +24%, Candel Therapeutics (NASDAQ:CADL) +20%. Losers: Flora Growth (NASDAQ:FLGC) -10%,&#...

VVOS - SKLZ Stock: The Reddit M&A Chatter Giving Skillz Shares a Lift Today

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Skillz (NYSE: SKLZ ) stock is on the rise Monday as investors on Reddit WallStreetBets talk about its potential as a takeover target. Source: NYCStock / Shutterstock.com Traders on Reddit are taking interest i...
VVOS - VVOS Stock: The Sleep Apnea Device News That Is Waking Up Vivos Therapeutics Shares

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Vivos Therapeutics (NASDAQ: VVOS ) stock is taking off on Monday morning after revealing clearance from the U.S. Food and Drug Administration (FDA) for its sleep apnea device. Source: tommaso79/Shutterstock.com ...

VVOS - InvestorNewsBreaks - Vivos Therapeutics Inc. (NASDAQ: VVOS) Receives FDA Clearance for mmRNA Oral Appliance

Vivos Therapeutics (NASDAQ: VVOS) , a medical technology company focused on developing and commercializing innovative diagnostic and treatment modalities for patients suffering from sleep-disordered breathing, including mild-to-moderate obstructive sleep apnea (“OSA”), has rec...

VVOS - MARA, BNTX and CARA among pre market gainers

Trillium Therapeutics (NASDAQ:TRIL) +191% after acquisition by Pfizer for $2.3B Vivos Therapeutics (NASDAQ:VVOS) +61% on FDA 510k clearance for sleep apnea treatment device Xeris Pharmaceuticals (NASDAQ:XERS) +48% announces approval of supplemental new drug Application (sN...
Previous 10 Next 10